DRKS00031932
Not yet recruiting
Not Applicable
Evaluation of upper gastrointestinal tract surveillance in individuals with Lynch syndrome - EARLY study
ationales Zentrum für erbliche Tumorerkrankungen, Universitätsklinikum Bonn0 sites5,000 target enrollmentAugust 5, 2024
Conditionsynch Syndrome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- ynch Syndrome
- Sponsor
- ationales Zentrum für erbliche Tumorerkrankungen, Universitätsklinikum Bonn
- Enrollment
- 5000
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Signed informed consent
- •\- Patient must be able to follow study instructions and expected to attend and complete all required study visits.
- •\-Confirmed diagnosis of a (likely\-) pathogenic germline variant in MLH1, MHS2, MSH6, PMS2 or EPCAM (Lynch Syndrome)
Exclusion Criteria
- •\-Subjects without legal capacity who are unable to understand the nature, scope, significance and consequences of this clinical trial
- •\- Patients with a physical or mental condition that, in the judgment of the investigator, could pose a risk to the patient, confound the study results, or interfere with participation in the clinical study
- •\- Personal history of duodenal or gastric surgery
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Observation of the upper gastrointestinal tract lesions by epinephrine sprayingesophageal cancer, gastric cancerJPRN-UMIN000017722Keio University,School of Medicine50
Recruiting
Phase 3
Extracorporeal magnetic navigation system of capsule endoscopyGastrointestinal Malignant Tumor, Gastric or Duodenal Ulcer, Gastrointestinal Bleeding,Gastrointestinal Benign Tumor, Inflammatory Bowel Disease, Gastrointestinal screeningJPRN-jRCT1092220114Hidetoshi Ohta40
Recruiting
Not Applicable
Investigation of the upper-gastrointestinal lesions using endocytoscopy systemupper-gastrointestinal lesionsJPRN-UMIN000034449Saitama Medical Center, Saitama Medical University500
Completed
Phase 4
Clinical investigation of upper gastrointestinal mucosal injury in patients receiving antiplatelet agents as a single agent or in combination: A randomaized control study in healthy volunteers.pper gastrointestinal mucosal injury by antiplatelet agentsJPRN-UMIN000008311Hyogo College of Medicine32
Recruiting
Not Applicable
Endoscopic evaluation for gastrointestinal functioFunctional gastrointestinal disorders(FGIDs), Esophageal motility disordersJPRN-UMIN000048384Graduate School of Medicine, Kyushu University200